A significant reduction in TNFα in the prostate of the PPE treatment group suggests that anti-inflammatory agents are involved in the mechanism of PPE in BPH treatment, but more investigation of other cytokines will be needed to further reinforce our conclusions. This evidence concerns the gene TNF and benign prostatic hyperplasia.